Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jebaraj BMC"'
Autor:
Jebaraj BMC; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany., Liew M; ARUP Institute for Clinical and Experimental Pathology®, Salt Lake City, UT, United States., Seyfried F; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 May 02; Vol. 14, pp. 1412843. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).
Autor:
Bruedigam C; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Claudia.Bruedigam@QIMRBerghofer.edu.au.; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia. Claudia.Bruedigam@QIMRBerghofer.edu.au., Porter AH; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Song A; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Vroeg In de Wei G; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Stoll T; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Straube J; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia., Cooper L; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Cheng G; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Kahl VFS; Telomere Length Regulation Unit, Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, New South Wales, Australia., Sobinoff AP; Telomere Length Regulation Unit, Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, New South Wales, Australia., Ling VY; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Jebaraj BMC; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Janardhanan Y; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Haldar R; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Bray LJ; Faculty of Engineering, School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, Queensland, Australia., Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany., Heidel FH; Hematology, Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald, Greifswald, Germany.; Leibniz Institute on Aging, Jena, Germany., Kennedy GA; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Hill MM; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Pickett HA; Telomere Length Regulation Unit, Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, New South Wales, Australia., Abdel-Wahab O; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hartel G; Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Lane SW; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Steven.Lane@QIMRBerghofer.edu.au.; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia. Steven.Lane@QIMRBerghofer.edu.au.; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. Steven.Lane@QIMRBerghofer.edu.au.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Jan; Vol. 5 (1), pp. 47-65. Date of Electronic Publication: 2023 Oct 30.
Autor:
Qi J; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Endres S; Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University, Ulm, Germany., Yosifov DY; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Tausch E; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Dheenadayalan RP; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Gao X; Department of Internal Medicine III, Ulm University, Ulm, Germany., Müller A; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Schneider C; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Mertens D; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Cooperation Unit 'Mechanisms of Leukemogenesis', German Cancer Research Center, Heidelberg, Germany., Gierschik P; Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University, Ulm, Germany., Wist M; Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University, Ulm, Germany., Jebaraj BMC; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Stilgenbauer S; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.
Publikováno v:
Blood advances [Blood Adv] 2023 Oct 10; Vol. 7 (19), pp. 5698-5702.
Autor:
Tausch E; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University, Ulm, Germany., Ljungström V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Agathangelidis A; Università Vita-Salute San Raffaele and Ospedale San Raffaele, Milan, Italy.; Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece., Zapatka M; German Cancer Research Center, Heidelberg, Germany., Scarfò L; Università Vita-Salute San Raffaele and Ospedale San Raffaele, Milan, Italy., Jebaraj BMC; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University, Ulm, Germany., Yosifov DY; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University, Ulm, Germany.; German Cancer Research Center, Heidelberg, Germany., Müller A; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University, Ulm, Germany., Munugalavadla V; Translational Medicine, Hematology Research and Development, AstraZeneca, South San Francisco, CA., Degenhardt JD; Research and Development, Maverick Therapeutics, Brisbane, CA., Ghia P; Università Vita-Salute San Raffaele and Ospedale San Raffaele, Milan, Italy., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; and.; Clinical Genetics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden., Stilgenbauer S; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University, Ulm, Germany.
Publikováno v:
Blood [Blood] 2022 Jun 02; Vol. 139 (22), pp. 3340-3344.
Autor:
Bloehdorn J; Department of Internal Medicine III, University of Ulm, Ulm., Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg., Holzmann K; Genomics Core Facility, University of Ulm, Ulm., Gerhardinger A; Genomics Core Facility, University of Ulm, Ulm., Jebaraj BMC; Department of Internal Medicine III, University of Ulm, Ulm., Bahlo J; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne., Humphrey K; Clinical Development Oncology, Roche Products Ltd, Welwyn Garden City., Tausch E; Department of Internal Medicine III, University of Ulm, Ulm., Robrecht S; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne., Mertens D; Department of Internal Medicine III, University of Ulm, Ulm, Germany; German Cancer Research Center (DKFZ), Heidelberg., Schneider C; Department of Internal Medicine III, University of Ulm, Ulm., Fischer K; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne., Hallek M; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne., Döhner H; Department of Internal Medicine III, University of Ulm, Ulm., Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg., Stilgenbauer S; Department of Internal Medicine III, University of Ulm, Ulm. stephan.stilgenbauer@uniklinik-ulm.de.
Publikováno v:
Haematologica [Haematologica] 2022 Mar 01; Vol. 107 (3), pp. 615-624. Date of Electronic Publication: 2022 Mar 01.
Autor:
Jebaraj BMC; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany., Müller A; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany., Dheenadayalan RP; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany., Endres S; Institute of Pharmacology and Toxicology, Ulm University, Ulm, Germany., Roessner PM; Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Seyfried F; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany., Walliser C; Institute of Pharmacology and Toxicology, Ulm University, Ulm, Germany., Wist M; Institute of Pharmacology and Toxicology, Ulm University, Ulm, Germany., Qi J; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany., Tausch E; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany., Mertens D; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany.; Cooperation Unit 'Mechanisms of Leukemogenesis', German Cancer Research Center, Heidelberg, Germany., Fox JA; Sunesis Pharmaceuticals, Inc., South San Francisco, CA; and., Debatin KM; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany., Meyer LH; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany., Taverna P; Sunesis Pharmaceuticals, Inc., South San Francisco, CA; and., Seiffert M; Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Gierschik P; Institute of Pharmacology and Toxicology, Ulm University, Ulm, Germany., Stilgenbauer S; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany.; Comprehensive Cancer Center Ulm, Ulm University Medical Center, Ulm, Germany.
Publikováno v:
Blood [Blood] 2022 Feb 10; Vol. 139 (6), pp. 859-875.
Autor:
Bloehdorn J; Department of Internal Medicine III, University of Ulm, Ulm, Germany. johannes.bloehdorn@gmail.com., Braun A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Taylor-Weiner A; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Jebaraj BMC; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Robrecht S; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne, Germany., Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Pan H; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Giza A; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne, Germany., Akylzhanova G; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Holzmann K; Genomics Core Facility, Ulm University, Ulm, Germany., Scheffold A; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Johnston HE; Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Yeh RF; Biostatistics, Genentech Inc., South San Francisco, CA, USA., Klymenko T; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Tausch E; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Eichhorst B; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne, Germany., Bullinger L; Medical Clinic for Hematology, Oncology and Tumor Biology, Charité University Hospital, Berlin, Germany., Fischer K; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne, Germany., Weisser M; Roche Pharma Research and Early Development, Penzberg, Germany., Robak T; Department of Hematology, Medical University of Lodz, Lodz, Poland., Schneider C; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Dahal LN; Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Department of Pharmacology and Therapeutics, Faculty of Life and Health Sciences, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Carter MJ; Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Elemento O; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Landau DA; Cancer Genomics and Evolutionary Dynamics, Weill Cornell Medicine, New York, NY, USA.; New York Genome Center, New York, NY, USA., Neuberg DS; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Cragg MS; Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Hallek M; Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne, Germany., Wu CJ; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Döhner H; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Stilgenbauer S; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Mertens D; Department of Internal Medicine III, University of Ulm, Ulm, Germany. d.mertens@dkfz-heidelberg.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. d.mertens@dkfz-heidelberg.de.
Publikováno v:
Nature communications [Nat Commun] 2021 Sep 13; Vol. 12 (1), pp. 5395. Date of Electronic Publication: 2021 Sep 13.
Autor:
Jebaraj BMC; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Stilgenbauer S; Department of Internal Medicine III, University of Ulm, Ulm, Germany.; Klinik für Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Jan 15; Vol. 10, pp. 612665. Date of Electronic Publication: 2021 Jan 15 (Print Publication: 2020).
Autor:
Edelmann J; Department of Internal Medicine III, Ulm University, Ulm, Germany jennifer.edelmann@uniklinik-ulm.de.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Holzmann K; Genomics Core Facility, Ulm University, Ulm, Germany., Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany., Saunderson EA; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Jebaraj BMC; Department of Internal Medicine III, Ulm University, Ulm, Germany., Steinbrecher D; Department of Internal Medicine III, Ulm University, Ulm, Germany., Dolnik A; Department of Internal Medicine III, Ulm University, Ulm, Germany., Blätte TJ; Department of Internal Medicine III, Ulm University, Ulm, Germany., Landau DA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; New York Genome Center, New York, NY, USA., Saub J; Department of Internal Medicine III, Ulm University, Ulm, Germany., Estenfelder S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Ibach S; Wissenschaftlicher Service Pharma GmbH (WiSP), Langenfeld, Germany., Cymbalista F; Service d'Hématologie Biologique, Hôpital Avicenne, Bobigny, France., Leblond V; Service d'Hématologie, Hôpital Pitié-Salpêtrière, Paris, France., Delmer A; Service d'Hématologie Clinique, CHU de Reims, Reims, France., Bahlo J; Department of Internal Medicine I, University of Cologne, Cologne, Germany., Robrecht S; Department of Internal Medicine I, University of Cologne, Cologne, Germany., Fischer K; Department of Internal Medicine I, University of Cologne, Cologne, Germany., Goede V; Department of Internal Medicine I, University of Cologne, Cologne, Germany., Bullinger L; Department of Internal Medicine III, Ulm University, Ulm, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany., Wu CJ; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Mertens D; Department of Internal Medicine III, Ulm University, Ulm, Germany., Ficz G; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Gribben JG; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Hallek M; Department of Internal Medicine I, University of Cologne, Cologne, Germany., Döhner H; Department of Internal Medicine III, Ulm University, Ulm, Germany., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany.
Publikováno v:
Haematologica [Haematologica] 2020 May; Vol. 105 (5), pp. 1379-1390. Date of Electronic Publication: 2019 Aug 29.
Autor:
Patil P; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany., Cieslak A; Diagnostic Haematology, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris, Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut national de recherche médicale (INSERM), Paris, France., Bernhart SH; Interdisciplinary Center for Bioinformatics, Transcriptome Bioinformatics, University of Leipzig, Leipzig, Germany., Toprak UH; Bioinformatics and Omics Data Analytics, German Cancer Research Center, Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Division Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany., Wagener R; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany.; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany., López C; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany.; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany., Wiehle L; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany., Bens S; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany.; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany., Altmüller J; Cologne Center for Genomics, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany., Franitza M; Cologne Center for Genomics, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany., Scholz I; Omics IT and Data Management Core Facility, German Cancer Research Center, Heidelberg, Germany., Jayne S; Ernest and Helen Scott Haematological Research Institute, Department of Cancer Studies, University of Leicester, Leicester, UK., Ahearne MJ; Ernest and Helen Scott Haematological Research Institute, Department of Cancer Studies, University of Leicester, Leicester, UK., Scheffold A; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Jebaraj BMC; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Schneider C; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Costa D; Haematopathology Section, Hospital Clínic, Institut d'Investigaciones Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Braun T; Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Schrader A; Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Campo E; Haematopathology Section, Hospital Clínic, Institut d'Investigaciones Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Dyer MJS; Ernest and Helen Scott Haematological Research Institute, Department of Cancer Studies, University of Leicester, Leicester, UK., Nürnberg P; Cologne Center for Genomics, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany., Dürig J; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Johansson P; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Böttcher S; Department III of Internal Medicine, University Hospital Rostock, Rostock, Germany., Schlesner M; Bioinformatics and Omics Data Analytics, German Cancer Research Center, Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Herling M; Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Stilgenbauer S; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Macintyre E; Diagnostic Haematology, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris, Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut national de recherche médicale (INSERM), Paris, France., Siebert R; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany.; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
Publikováno v:
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2020 Apr; Vol. 59 (4), pp. 261-267. Date of Electronic Publication: 2019 Nov 29.